These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Blockade of NKG2D synergized with CTLA4-Ig in promoting long-term graft survival in murine models of cardiac transplantation. Li J; Zhu H; Wang S; Ye P; Liu C; Wu J; Xia J Transplantation; 2012 Feb; 93(4):356-63. PubMed ID: 22179404 [TBL] [Abstract][Full Text] [Related]
31. Immunologic characterization of murine cardiac allograft recipients with long-term graft survival due to anti-VCAM-1 or anti-CD4 monoclonal antibody therapy. Orosz CG; Bergese SD; Huang EH; Vanbuskirk AM Transplant Proc; 1995 Feb; 27(1):387-8. PubMed ID: 7533414 [No Abstract] [Full Text] [Related]
32. Positive effects of anti-T-cell monoclonal antibodies on rat allograft survival. Claesson K; Larsson P; Holmdahl R; Klareskog L; Forsum U; Tufveson G Transplant Proc; 1987 Feb; 19(1 Pt 1):615-6. PubMed ID: 3079163 [No Abstract] [Full Text] [Related]
33. Differential immunosuppressive activity of monoclonal CD2 antibodies on allograft rejection versus specific antibody production. Sido B; Dengler TJ; Otto G; Zimmermann R; Müller P; Meuer SC Eur J Immunol; 1998 Apr; 28(4):1347-57. PubMed ID: 9565375 [TBL] [Abstract][Full Text] [Related]
34. Anti-interleukin-2 receptor (IL-2R) antibody against rejection of organ grafts. Kupiec-Weglinski JW; Padberg W; Uhteg LC; Towpik E; Lord RH; Ma L; Diamantstein T; Strom TB; Tilney NL Transplant Proc; 1987 Feb; 19(1 Pt 1):591-3. PubMed ID: 2978926 [No Abstract] [Full Text] [Related]
35. Anti-CD2 monoclonal antibodies synergize with anti-CD3 to prolong allograft survival and decrease cytokine production. Chavin KD; Qin L; Lin J; Kaplan AJ; Bromberg JS Transplant Proc; 1993 Feb; 25(1 Pt 1):823-4. PubMed ID: 8094913 [No Abstract] [Full Text] [Related]
36. Immunosuppressive antibody treatment prolongs graft survival in two murine models of segmental pancreas transplantation. Purcell LJ; Mottram PL; Mandel TE Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():349-52. PubMed ID: 8225401 [TBL] [Abstract][Full Text] [Related]
37. Inhibitory effects of anti-interleukin 2 receptor and anti-L3T4 antibodies on delayed type hypersensitivity: the role of complement and epitope. Kelley VE; Gaulton GN; Strom TB J Immunol; 1987 May; 138(9):2771-5. PubMed ID: 3106488 [TBL] [Abstract][Full Text] [Related]
38. Pretreatment with cyclosporin A (CyA) and anti-interleukin 2 receptor monoclonal antibody (IL-2R MAb) abrogates the anti-idiotype response in rat recipients of cardiac allografts. Tanaka K; Kupiec-Weglinski JW; Hancock WW; Stunkel K; Diamantstein T; Tilney NL Transplant Proc; 1991 Feb; 23(1 Pt 1):281-2. PubMed ID: 1990532 [No Abstract] [Full Text] [Related]
39. Trichinella spiralis infection changes immune response in mice performed abdominal heterotopic cardiac transplantation and prolongs cardiac allograft survival time. Deng G; Deng R; Yao J; Liao B; Chen Y; Wu Z; Hu H; Zhou X; Ma Y Parasitol Res; 2016 Jan; 115(1):407-14. PubMed ID: 26481486 [TBL] [Abstract][Full Text] [Related]
40. Negative and positive co-signaling with anti-BTLA (PJ196) and CTLA4Ig prolongs islet allograft survival. Truong W; Plester JC; Hancock WW; Kaye J; Merani S; Murphy KM; Murphy TL; Anderson CC; Shapiro AM Transplantation; 2007 Nov; 84(10):1368-72. PubMed ID: 18049125 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]